[1] |
QIN Xian, WANG Qian, HOU Jia, XU Dongmei.
Stains: recent research progress for endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 488-494.
|
[2] |
LUO Liting, JIN Jing.
A case analysis of medication adjustments on a moyamoya disease patient with endometriosis by DAPT treatment during perioperative period and formulation of DIE postoperative recurrence prevention
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 495-500.
|
[3] |
GUO Hua, LIU Lanlan, HUANG Chunzhi, SUN Nan, REN Yanli.
Rapid health technology assessment of dienogest in the treatment of endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 512-519.
|
[4] |
ZHANG Baoyin, YANG Wenhui, LIU Qinglan, WANG Chen, WU Jing, LIU Qian, SUN Nan.
Multidimensional analysis of endometriosis clinical trials based on the ClinicalTrials.gov database
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 520-526.
|
[5] |
LIU Qian, ZHANG Jianing, ZHANG Shuang, LIU Qinglan, ZHANG Baoyin, SUN Nan.
Comparison of clinical effectiveness and safety between generic and branded dienogest tablets in the treatment of endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 527-534.
|
[6] |
HUANG Chunzhi, LIU Qinglan, SU Ran, SUN Nan.
Drug treatment options and research progress of adolescent endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 535-542.
|
[7] |
ZHANG Zhipeng, CHEN Ziqi, TIAN Jianhui.
The attenuating and potentiating effects of traditional Chinese medicine in immune checkpoint therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 339-347.
|
[8] |
YU Miaoying, WANG Yanhui, YAN Shi.
Research progress on molecular mechanism of traditional chinese medicine active ingredients interfering bone marrow mesenchymal stem cells senescence
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 99-106.
|
[9] |
HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie.
Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
|
[10] |
QIN Wenxiu, XU Junfeng, YANG Ting, WANG Pingfei.
Research progress on signaling pathway of tanshinoneIIA in treatment of nerve injury after ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 705-713.
|
[11] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[12] |
LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao.
Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
|
[13] |
QI Xiaofeng, LUO Yali, XIAO Mengyong, ZHOU Shiqin, ZHOU Wen, AN Fangyu, WEI Benjun, LIU Yongqi.
Research status of dialectical prevention and treatment of acute lung injury based on the theory of "Wei qi and Ying Xue"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 429-437.
|
[14] |
DONG Li, ZHOU Feng.
Effects of remimazolam tosilate combined with remifentanil anesthesia on hemodynamics, serum IL-1β, CXCL8 levels in elderly patients undergoing spinal surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1372-1377.
|
[15] |
LI Tao, YANG Lixia, GAO Bo, LI Qin, SONG Shuang.
Research progress of JAK/STAT signaling pathway in the intervention of diabetic microvascular complications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1415-1421.
|